ID   PEAK1_HUMAN             Reviewed;        1746 AA.
AC   Q9H792; Q6ZS78; Q8NAZ4; Q8NCM3; Q8TEG7;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 4.
DT   15-MAR-2017, entry version 133.
DE   RecName: Full=Pseudopodium-enriched atypical kinase 1;
DE            EC=2.7.10.2;
DE   AltName: Full=Sugen kinase 269;
DE   AltName: Full=Tyrosine-protein kinase SgK269;
GN   Name=PEAK1; Synonyms=KIAA2002;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 537-1746.
RC   TISSUE=Lung, Mesangial cell, and Smooth muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 707-1120.
RC   TISSUE=Spleen;
RA   Jikuya H., Takano J., Nomura N., Kikuno R., Nagase T., Ohara O.;
RT   "The nucleotide sequence of a long cDNA clone isolated from human
RT   spleen.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 983-1746.
RC   TISSUE=Brain;
RX   PubMed=12056414; DOI=10.1093/dnares/9.2.47;
RA   Ohara O., Nagase T., Mitsui G., Kohga H., Kikuno R., Hiraoka S.,
RA   Takahashi Y., Kitajima S., Saga Y., Koseki H.;
RT   "Characterization of size-fractionated cDNA libraries generated by the
RT   in vitro recombination-assisted method.";
RL   DNA Res. 9:47-57(2002).
RN   [5]
RP   IDENTIFICATION.
RX   PubMed=12471243; DOI=10.1126/science.1075762;
RA   Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S.;
RT   "The protein kinase complement of the human genome.";
RL   Science 298:1912-1934(2002).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-540 AND SER-587, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH BCAR1 AND CRK,
RP   SUBCELLULAR LOCATION, AUTOPHOSPHORYLATION, AND PHOSPHORYLATION BY CSK.
RX   PubMed=20534451; DOI=10.1073/pnas.0914776107;
RA   Wang Y., Kelber J.A., Tran Cao H.S., Cantin G.T., Lin R., Wang W.,
RA   Kaushal S., Bristow J.M., Edgington T.S., Hoffman R.M., Bouvet M.,
RA   Yates J.R. III, Klemke R.L.;
RT   "Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton
RT   and cancer progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:10920-10925(2010).
RN   [10]
RP   ERRATUM.
RA   Wang Y., Kelber J.A., Tran Cao H.S., Cantin G.T., Lin R., Wang W.,
RA   Kaushal S., Bristow J.M., Edgington T.S., Hoffman R.M., Bouvet M.,
RA   Yates J.R. III, Klemke R.L.;
RL   Proc. Natl. Acad. Sci. U.S.A. 107:13556-13556(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-281 AND TYR-635, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-281; SER-572; SER-587;
RP   SER-648; SER-854; SER-898; THR-1151 AND SER-1374, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1151, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-213; ILE-240; PRO-440; GLN-611;
RP   ILE-792; GLU-836; PHE-1035; LYS-1071; PRO-1077; LEU-1145; GLN-1408;
RP   THR-1542 AND GLY-1699.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Tyrosine kinase that may play a role in cell spreading
CC       and migration on fibronectin. May directly or indirectly affect
CC       phosphorylation levels of cytoskeleton-associated proteins
CC       MAPK1/ERK and PXN. {ECO:0000269|PubMed:20534451}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028, ECO:0000269|PubMed:20534451}.
CC   -!- SUBUNIT: Interacts with BCAR1 and CRK.
CC       {ECO:0000269|PubMed:20534451}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:20534451}. Cell junction, focal adhesion
CC       {ECO:0000269|PubMed:20534451}. Note=Colocalizes with F-actin in
CC       serum-rich medium. Actin colocalization is reduced during serum
CC       starvation.
CC   -!- PTM: Phosphorylated on tyrosine in a CSK-dependent manner in
CC       response to adhesion to fibronectin and to EGF stimulation.
CC       Autophosphorylated in vitro. {ECO:0000269|PubMed:20534451}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15006.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAC87076.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC087465; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC107883; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK024793; BAB15006.1; ALT_INIT; mRNA.
DR   EMBL; AK091802; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK127658; BAC87076.1; ALT_INIT; mRNA.
DR   EMBL; AK074157; BAB84983.1; -; mRNA.
DR   EMBL; AB082533; BAC02711.1; -; mRNA.
DR   CCDS; CCDS42062.1; -.
DR   RefSeq; NP_079052.2; NM_024776.3.
DR   RefSeq; XP_005254727.1; XM_005254670.2.
DR   RefSeq; XP_005254728.1; XM_005254671.2.
DR   RefSeq; XP_005254730.1; XM_005254673.2.
DR   RefSeq; XP_005254731.1; XM_005254674.2.
DR   RefSeq; XP_005254732.1; XM_005254675.4.
DR   RefSeq; XP_011520335.1; XM_011522033.2.
DR   RefSeq; XP_011520336.1; XM_011522034.2.
DR   RefSeq; XP_011520337.1; XM_011522035.2.
DR   RefSeq; XP_011520338.1; XM_011522036.2.
DR   RefSeq; XP_011520339.1; XM_011522037.2.
DR   RefSeq; XP_011520340.1; XM_011522038.2.
DR   RefSeq; XP_011520341.1; XM_011522039.2.
DR   UniGene; Hs.731402; -.
DR   UniGene; Hs.9587; -.
DR   ProteinModelPortal; Q9H792; -.
DR   BioGrid; 122926; 19.
DR   DIP; DIP-56276N; -.
DR   IntAct; Q9H792; 11.
DR   STRING; 9606.ENSP00000309230; -.
DR   ChEMBL; CHEMBL3627585; -.
DR   iPTMnet; Q9H792; -.
DR   PhosphoSitePlus; Q9H792; -.
DR   BioMuta; PEAK1; -.
DR   DMDM; 223634730; -.
DR   EPD; Q9H792; -.
DR   MaxQB; Q9H792; -.
DR   PaxDb; Q9H792; -.
DR   PeptideAtlas; Q9H792; -.
DR   PRIDE; Q9H792; -.
DR   DNASU; 79834; -.
DR   Ensembl; ENST00000312493; ENSP00000309230; ENSG00000173517.
DR   Ensembl; ENST00000560626; ENSP00000452796; ENSG00000173517.
DR   GeneID; 79834; -.
DR   KEGG; hsa:79834; -.
DR   UCSC; uc059lyw.1; human.
DR   CTD; 79834; -.
DR   DisGeNET; 79834; -.
DR   GeneCards; PEAK1; -.
DR   H-InvDB; HIX0012463; -.
DR   HGNC; HGNC:29431; PEAK1.
DR   HPA; HPA026313; -.
DR   HPA; HPA026517; -.
DR   MIM; 614248; gene.
DR   neXtProt; NX_Q9H792; -.
DR   OpenTargets; ENSG00000173517; -.
DR   eggNOG; ENOG410IJMD; Eukaryota.
DR   eggNOG; ENOG4110SRP; LUCA.
DR   GeneTree; ENSGT00460000041554; -.
DR   HOVERGEN; HBG093946; -.
DR   InParanoid; Q9H792; -.
DR   KO; K17538; -.
DR   OMA; NDCYKRS; -.
DR   OrthoDB; EOG091G03K2; -.
DR   PhylomeDB; Q9H792; -.
DR   SignaLink; Q9H792; -.
DR   ChiTaRS; PEAK1; human.
DR   GenomeRNAi; 79834; -.
DR   PRO; PR:Q9H792; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000173517; -.
DR   ExpressionAtlas; Q9H792; baseline and differential.
DR   Genevisible; Q9H792; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0016477; P:cell migration; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell junction; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Kinase; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transferase;
KW   Tyrosine-protein kinase.
FT   CHAIN         1   1746       Pseudopodium-enriched atypical kinase 1.
FT                                /FTId=PRO_0000250589.
FT   DOMAIN     1313   1675       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND    1319   1327       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COMPBIAS    117    120       Poly-Asn.
FT   COMPBIAS    324    406       Ser-rich.
FT   COMPBIAS    500    503       Poly-Ser.
FT   COMPBIAS    776    873       Pro-rich.
FT   COMPBIAS    964    967       Poly-Pro.
FT   ACT_SITE   1516   1516       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING    1359   1359       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     281    281       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     540    540       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     572    572       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     587    587       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     635    635       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     641    641       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q69Z38}.
FT   MOD_RES     648    648       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     826    826       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q69Z38}.
FT   MOD_RES     854    854       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     898    898       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1151   1151       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1374   1374       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT     213    213       G -> R (in dbSNP:rs35459975).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041817.
FT   VARIANT     240    240       V -> I (in dbSNP:rs56129428).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041818.
FT   VARIANT     440    440       S -> P (in dbSNP:rs35335169).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041819.
FT   VARIANT     611    611       H -> Q (in a bladder carcinoma NOS
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041820.
FT   VARIANT     792    792       S -> I (in dbSNP:rs34885462).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041821.
FT   VARIANT     836    836       D -> E (in dbSNP:rs56388121).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041822.
FT   VARIANT    1035   1035       S -> F (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041823.
FT   VARIANT    1071   1071       R -> K (in dbSNP:rs12909704).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041824.
FT   VARIANT    1077   1077       T -> P (in dbSNP:rs56133554).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041825.
FT   VARIANT    1145   1145       P -> L (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041826.
FT   VARIANT    1408   1408       P -> Q (in dbSNP:rs56079860).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041827.
FT   VARIANT    1542   1542       S -> T (in dbSNP:rs1867780).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041828.
FT   VARIANT    1699   1699       R -> G (in dbSNP:rs34004337).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041829.
FT   CONFLICT    779    779       S -> F (in Ref. 2; BAC87076).
FT                                {ECO:0000305}.
FT   CONFLICT   1046   1049       SHMT -> RYVK (in Ref. 2; AK091802).
FT                                {ECO:0000305}.
FT   CONFLICT   1112   1120       QSRAAMIPP -> KCKCPISSI (in Ref. 3;
FT                                BAB84983). {ECO:0000305}.
FT   CONFLICT   1375   1378       LAVR -> SQEF (in Ref. 2; BAC87076).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1746 AA;  193106 MW;  7C9A9F60BBCF6C61 CRC64;
     MSACNTFTEH VWKPGECKNC FKPKSLHQLP PDPEKAPITH GNVKTNANHS NNHRIRNTGN
     FRPPVAKKPT IAVKPTMIVA DGQSICGELS IQEHCENKPV IIGWNRNRAA LSQKPLNNNN
     EDDEGISHVP KPYGNNDSAK KMSDNNNGLT EVLKEIAGLD TAPQIRGNET NSRETFLGRI
     NDCYKRSLER KLPPSCMIGG IKETQGKHVI LSGSTEVISN EGGRFCYPEF SSGEESEEDV
     LFSNMEEEHE SWDESDEELL AMEIRMRGQP RFANFRANTL SPVRFFVDKK WNTIPLRNKS
     LQRICAVDYD DSYDEILNGY EENSVVSYGQ GSIQSMVSSD STSPDSSLTE ESRSETASSL
     SQKICNGGLS PGNPGDSKDM KEIEPNYESP SSNNQDKDSS QASKSSIKVP ETHKAVLALR
     LEEKDGKIAV QTEKEESKAS TDVAGQAVTI NLVPTEEQAK PYRVVNLEQP LCKPYTVVDV
     SAAMASEHLE GPVNSPKTKS SSSTPNSPVT SSSLTPGQIS AHFQKSSAIR YQEVWTSSTS
     PRQKIPKVEL ITSGTGPNVP PRKNCHKSAP TSPTATNISS KTIPVKSPNL SEIKFNSYNN
     AGMPPFPIII HDEPTYARSS KNAIKVPIVI NPNAYDNLAI YKSFLGTSGE LSVKEKTTSV
     ISHTYEEIET ESKVPDNTTS KTTDCLQTKG FSNSTEHKRG SVAQKVQEFN NCLNRGQSSP
     QRSYSSSHSS PAKIQRATQE PVAKIEGTQE SQMVGSSSTR EKASTVLSQI VASIQPPQSP
     PETPQSGPKA CSVEELYAIP PDADVAKSTP KSTPVRPKSL FTSQPSGEAE APQTTDSPTT
     KVQKDPSIKP VTPSPSKLVT SPQSEPPAPF PPPRSTSSPY HAGNLLQRHF TNWTKPTSPT
     RSTEAESVLH SEGSRRAADA KPKRWISFKS FFRRRKTDEE DDKEKEREKG KLVGLDGTVI
     HMLPPPPVQR HHWFTEAKGE SSEKPAIVFM YRCDPAQGQL SVDQSKARTD QAAVMEKGRA
     ENALLQDSEK KRSHSSPSQI PKKILSHMTH EVTEDFSPRD PRTVVGKQDG RGCTSVTTAL
     SLPELEREDG KEDISDPMDP NPCSATYSNL GQSRAAMIPP KQPRQPKGAV DDAIAFGGKT
     DQEAPNASQP TPPPLPKKMI IRANTEPISK DLQKSMESSL CVMANPTYDI DPNWDASSAG
     SSISYELKGL DIESYDSLER PLRKERPVPS AANSISSLTT LSIKDRFSNS MESLSSRRGP
     SCRQGRGIQK PQRQALYRGL ENREEVVGKI RSLHTDALKK LAVKCEDLFM AGQKDQLRFG
     VDSWSDFRLT SDKPCCEAGD AVYYTASYAK DPLNNYAVKI CKSKAKESQQ YYHSLAVRQS
     LAVHFNIQQD CGHFLAEVPN RLLPWEDPDD PEKDEDDMEE TEEDAKGETD GKNPKPCSEA
     ASSQKENQGV MSKKQRSHVV VITREVPCLT VADFVRDSLA QHGKSPDLYE RQVCLLLLQL
     CSGLEHLKPY HVTHCDLRLE NLLLVHYQPG GTAQGFGPAE PSPTSSYPTR LIVSNFSQAK
     QKSHLVDPEI LRDQSRLAPE IITATQYKKC DEFQTGILIY EMLHLPNPFD ENPELKEREY
     TRADLPRIPF RSPYSRGLQQ LASCLLNPNP SERILISDAK GILQCLLWGP REDLFQTFTA
     CPSLVQRNTL LQNWLDIKRT LLMIKFAEKS LDREGGISLE DWLCAQYLAF ATTDSLSCIV
     KILQHR
//
